51 related articles for article (PubMed ID: 1358436)
1. Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor.
Russell KS; Hung MC
Cancer Res; 1992 Dec; 52(23):6624-9. PubMed ID: 1358436
[TBL] [Abstract][Full Text] [Related]
2. Repression of insulin gene transcription by indirect genomic signaling via the estrogen receptor in pancreatic beta cells.
Sekido T; Nishio SI; Ohkubo Y; Sekido K; Kitahara J; Miyamoto T; Komatsu M
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):226-236. PubMed ID: 30790128
[TBL] [Abstract][Full Text] [Related]
3. MiR-139 Modulates Cancer Stem Cell Function of Human Breast Cancer through Targeting CXCR4.
Cheng CW; Liao WL; Chen PM; Yu JC; Shiau HP; Hsieh YH; Lee HJ; Cheng YC; Wu PE; Shen CY
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070538
[TBL] [Abstract][Full Text] [Related]
4. HER-2/Neu and Hormone Receptor Analysis in Breast Carcinomas and Their Association with Clinicopathologic Parameters.
Köseoğlu RD; Markoç F; Müslehiddinoğlu A; İleri AB; Deresoy FA; Etikan İ
Eur J Breast Health; 2019 Jan; 15(1):43-50. PubMed ID: 30816354
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Immunohistochemistry-Equivocal (2+) HER2 Gene Status in Invasive Breast Cancer by Silver DNA in Situ Hybridization (SISH) and its Association with Clinicopathological Variables.
A Musa Z; J Qasim B; A K Al Shaikhly AW
Iran J Pathol; 2017; 12(1):9-19. PubMed ID: 29760748
[TBL] [Abstract][Full Text] [Related]
6. Association between hormone receptors and HER-2/neu is age-related.
Wang B; Wang X; Zou Y
Int J Clin Exp Pathol; 2015; 8(7):8472-9. PubMed ID: 26339420
[TBL] [Abstract][Full Text] [Related]
7. Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.
Awasthi S; Hamburger AW
J Cell Physiol; 2014 Nov; 229(11):1831-41. PubMed ID: 24692179
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.
Garee JP; Chien CD; Li JV; Wellstein A; Riegel AT
Mol Endocrinol; 2014 Jun; 28(6):846-59. PubMed ID: 24678732
[TBL] [Abstract][Full Text] [Related]
9. Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.
Flågeng MH; Knappskog S; Haynes BP; Lønning PE; Mellgren G
PLoS One; 2013; 8(8):e74618. PubMed ID: 23991224
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy for HER2 positive breast cancer.
Incorvati JA; Shah S; Mu Y; Lu J
J Hematol Oncol; 2013 Jun; 6():38. PubMed ID: 23731980
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 in breast cancer progression.
Todorović-Raković N; Milovanović J
J Interferon Cytokine Res; 2013 Oct; 33(10):563-70. PubMed ID: 23697558
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform.
Abramovitz M; Barwick BG; Willis S; Young B; Catzavelos C; Li Z; Kodani M; Tang W; Bouzyk M; Moreno CS; Leyland-Jones B
Br J Cancer; 2011 Nov; 105(10):1574-81. PubMed ID: 22067903
[TBL] [Abstract][Full Text] [Related]
13. Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells.
Sakla MS; Shenouda NS; Ansell PJ; Macdonald RS; Lubahn DB
Endocrine; 2007 Aug; 32(1):69-78. PubMed ID: 17992604
[TBL] [Abstract][Full Text] [Related]
14. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.
Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Vergote I; Christiaens MR
J Clin Pathol; 2005 Jun; 58(6):611-6. PubMed ID: 15917412
[TBL] [Abstract][Full Text] [Related]
15. Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland.
De Bortoli M; Dati C
J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):175-85. PubMed ID: 10882303
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.
Bates NP; Hurst HC
J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):153-63. PubMed ID: 10882301
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
Nakshatri H; Bhat-Nakshatri P; Martin DA; Goulet RJ; Sledge GW
Mol Cell Biol; 1997 Jul; 17(7):3629-39. PubMed ID: 9199297
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle.
Gompel A; Martin A; Simon P; Schoevaert D; Plu-Bureau G; Hugol D; Audouin J; Leygue E; Truc JB; Poitout P
Breast Cancer Res Treat; 1996; 38(2):227-35. PubMed ID: 8861841
[TBL] [Abstract][Full Text] [Related]
19. The significance of heregulin in breast cancer tumor progression and drug resistance.
Lupu R; Cardillo M; Cho C; Harris L; Hijazi M; Perez C; Rosenberg K; Yang D; Tang C
Breast Cancer Res Treat; 1996; 38(1):57-66. PubMed ID: 8825123
[TBL] [Abstract][Full Text] [Related]
20. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors.
Bacus SS; Chin D; Yarden Y; Zelnick CR; Stern DF
Am J Pathol; 1996 Feb; 148(2):549-58. PubMed ID: 8579117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
